£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

Exocrine Pancreatic Insufficiency Therapeutics Outlook 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 19 days · 19 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 11 August 2026 15 August 2026 20 August 2026 24 August 2026 29 August 2026
View at Amazon ↗

Price data last checked 72 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 19 days • 1 price levels

Days at Price
19 days 0 5 10 14 19 £520 Days at Price

Price Analysis

Most common price: £520 (19 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 19 days

Description

Gain professional insights with The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States. Published by ICON Group International, Inc., this specialized book provides a focused analysis of the therapeutic landscape for this condition within the US market. It serves as a strategic resource for those studying medical market trends and therapeutic developments through 2028. This publication offers a structured look at the evolving sector, making it a valuable addition to professional libraries and academic research collections.

Key Features

Provides a detailed outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States.

Covers market trends and therapeutic developments spanning the years 2023 through 2028.

Published by ICON Group International, Inc. for professional and academic use.

Categorized under Books > Subjects for easy integration into research collections.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

Exocrine Pancreatic Insufficiency Therapeutics India Outlook
99% match

Exocrine Pancreatic Insufficiency Therapeutics India Outlook

£515.00 28 Oct 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in China
99% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in China

£495.00 02 Sep 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in Japan
99% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in Japan

£495.00 31 Oct 2026
Exocrine Pancreatic Insufficiency Therapeutics Outlook 2023-2028
98% match

Exocrine Pancreatic Insufficiency Therapeutics Outlook 2023-2028

£490.00 28 Oct 2026
The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States
98% match

The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States

£595.00 08 Nov 2026
The 2021-2026 World Outlook for Pancreatic Cancer Drugs
97% match

The 2021-2026 World Outlook for Pancreatic Cancer Drugs

£795.00 04 Nov 2026
Pancreatic Cancer Drug Outlook: Africa & Middle East Study
97% match

Pancreatic Cancer Drug Outlook: Africa & Middle East Study

£325.00 07 Nov 2026
Pancreatic Cancer Drug Outlook 2013-2018 - North America
97% match

Pancreatic Cancer Drug Outlook 2013-2018 - North America

£325.00 25 Aug 2026
Pancreatic Cancer Drug Outlook in Latin America 2013-2018
97% match

Pancreatic Cancer Drug Outlook in Latin America 2013-2018

£325.00 26 Aug 2026
Multidisciplinary Management of Acute and Chronic Pancreatitis
97% match

Multidisciplinary Management of Acute and Chronic Pancreatitis

IntechOpen

£119.00 24 Sep 2026
Pancreatic Cancer Drug Outlook in Europe 2013-2018 Study
97% match

Pancreatic Cancer Drug Outlook in Europe 2013-2018 Study

£325.00 07 Nov 2026
The 2011-2016 Outlook for Pancreatic Cancer Drugs in The Middle East
97% match

The 2011-2016 Outlook for Pancreatic Cancer Drugs in The Middle East

£325.00 26 Aug 2026
Chronic Disease & Disability: The Pediatric Pancreas (Pediatrics, Child and Adolescent Health)
97% match

Chronic Disease & Disability: The Pediatric Pancreas (Pediatrics, Child and Adolescent Health)

Price unavailable
The 2026-2031 World Outlook for Smart Insulin Pens and Pumps
97% match

The 2026-2031 World Outlook for Smart Insulin Pens and Pumps

£885.00 02 Sep 2026
2023-2028 US E-Paper Outlook - Market Demand Study
96% match

2023-2028 US E-Paper Outlook - Market Demand Study

£520.00 06 Nov 2026
Peptides and Heparin for Diabetes Outlook 2023-2028 Study
96% match

Peptides and Heparin for Diabetes Outlook 2023-2028 Study

£520.00 28 Aug 2026
Chronic Pancreatitis
96% match

Chronic Pancreatitis

IntechOpen

£114.00 18 Sep 2026
Pancreatitis: Treatment and Complexities
96% match

Pancreatitis: Treatment and Complexities

Foster Academics

£58.79 18 Sep 2026
Plant-Based Proteins in India 2023-2028 Outlook Study
96% match

Plant-Based Proteins in India 2023-2028 Outlook Study

£515.00 05 Nov 2026
2023-2028 US Prepared Food Equipment Market Outlook Study
96% match

2023-2028 US Prepared Food Equipment Market Outlook Study

£520.00 03 Nov 2026
The 2023-2028 Outlook for Photo Printers in the United States
96% match

The 2023-2028 Outlook for Photo Printers in the United States

£520.00 03 Oct 2026
Chronic Pancreatitis: From Basic Research to Clinical Treatment
96% match

Chronic Pancreatitis: From Basic Research to Clinical Treatment

Springer

£99.99 12 Sep 2026
2023-2028 US Presentation Materials Outlook Report
96% match

2023-2028 US Presentation Materials Outlook Report

£520.00 28 Oct 2026
Pancreatic Cancer Drug Outlook in Africa 2011-2016 Study
96% match

Pancreatic Cancer Drug Outlook in Africa 2011-2016 Study

£325.00 26 Aug 2026